[{"address1": "7800 Susquehanna St.", "address2": "Suite 505", "city": "Pittsburgh", "state": "PA", "zip": "15208", "country": "United States", "phone": "412-901-0315", "website": "https://www.lipella.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan  Kaufman M.B.A., Ph.D.", "age": 57, "title": "Co-Founder, Chairman, CEO, President, Secretary & Treasurer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 204133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael B. Chancellor M.D.", "age": 65, "title": "Co-Founder, Chief Medical Officer & Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 195833, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas  Johnston CPA", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 185000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele  Gruber", "title": "Director of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katie  Johnston", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.65, "open": 4.16, "dayLow": 2.92, "dayHigh": 4.16, "regularMarketPreviousClose": 4.65, "regularMarketOpen": 4.16, "regularMarketDayLow": 2.92, "regularMarketDayHigh": 4.16, "forwardPE": -0.95937496, "volume": 2143248, "regularMarketVolume": 2143248, "averageVolume": 1580818, "averageVolume10days": 8718910, "averageDailyVolume10Day": 8718910, "bid": 3.9, "ask": 3.74, "bidSize": 100, "askSize": 100, "marketCap": 3711384, "fiftyTwoWeekLow": 2.21, "fiftyTwoWeekHigh": 12.0, "priceToSalesTrailing12Months": 7.31734, "fiftyDayAverage": 2.93736, "twoHundredDayAverage": 3.848115, "currency": "USD", "enterpriseValue": 1335580, "floatShares": 650777, "sharesOutstanding": 1208920, "sharesShort": 2273, "sharesShortPriorMonth": 22482, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0019, "heldPercentInsiders": 0.29374, "heldPercentInstitutions": 0.00877, "shortRatio": 0.01, "shortPercentOfFloat": 0.0026, "impliedSharesOutstanding": 1831100, "bookValue": 4.155, "priceToBook": 0.7388688, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -4142409, "trailingEps": -4.29, "forwardEps": -3.2, "lastSplitFactor": "1:8", "lastSplitDate": 1731024000, "enterpriseToRevenue": 2.633, "52WeekChange": -0.4128788, "SandP52WeekChange": 0.21142256, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "LIPO", "underlyingSymbol": "LIPO", "shortName": "Lipella Pharmaceuticals Inc.", "longName": "Lipella Pharmaceuticals Inc.", "firstTradeDateEpochUtc": 1671460200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d39a1b66-6fea-3b6c-8773-cda09b9e9d93", "messageBoardId": "finmb_35907207", "gmtOffSetMilliseconds": -18000000, "currentPrice": 3.07, "targetHighPrice": 10.0, "targetLowPrice": 10.0, "targetMeanPrice": 10.0, "targetMedianPrice": 10.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 1186506, "totalCashPerShare": 1.186, "totalDebt": 93679, "quickRatio": 2.544, "currentRatio": 4.332, "totalRevenue": 507204, "debtToEquity": 5.498, "revenuePerShare": 0.592, "returnOnAssets": -0.9377, "returnOnEquity": -1.71559, "grossProfits": -2284414, "freeCashflow": -2254496, "operatingCashflow": -3724304, "revenueGrowth": 0.279, "operatingMargins": -6.97927, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-08"}]